UNITED THERAPEUTICS CORPORATION

Business Segments United Therapeutics Corporation

Equities

UTHR

US91307C1027

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2024-09-06 EDT			5-day change	1st Jan Change
345.63 ^USD	-1.25%		-4.93%	+57.18%

09-05	Transcript : United Therapeutics Corporation Presents at Wells Fargo 2024 Healthcare Conference, Sep-05-2024 08:00 AM
09-04	United Therapeutics Insider Sold Shares Worth $2,821,050, According to a Recent SEC Filing	MT

Sales 2023 by Business Segment

See more © MarketScreener.com

Sales 2023 by Geography

See more © MarketScreener.com

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment

Fiscal Period: December	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Biological Products
Pharmaceuticals						1.45B	1.48B	1.69B	1.94B	2.33B
Total Assets						3.91B	4.62B	5.17B	6.04B	7.17B
Interest Expense						-44.2M	-23.5M	-18.6M	-32.4M	-59.3M
Income Tax Expense						-60.5M	124M	118M	223M	290M
CAPEX						-83.7M	-59.3M	-121M	-139M	-230M
EBT						-165M	639M	594M	951M	1.27B
D&A						45.9M	49.9M	49.9M	51.3M	53.2M
Operating Income						-188M	594M	556M	980M	1.18B
Net Income						-104M	515M	476M	727M	985M

Geographical Revenue Distribution History

Geographical breakdown of sales

Fiscal Period: December	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
United States						1.32B	1.41B	1.56B	1.81B	2.2B
Total Assets						723M	717M	768M	871M	1.06B
Rest of World						126M	71.2M	121M	122M	125M
Total Assets						15.4M	14.3M	12.8M	12.6M	12M

Stock Market
Equities
UTHR Stock
Financials United Therapeutics Corporation
Business Segments

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW